Test Bank for Fundamentals of Urine and Body Fluid Analysis, 3rd Edition : Brunzel

Original price was: $35.00.Current price is: $26.50.

Test Bank for Fundamentals of Urine and Body Fluid Analysis, 3rd Edition : Brunzel Digital Instant Download

Category:

This is completed downloadable of Test Bank for Fundamentals of Urine and Body Fluid Analysis, 3rd Edition : Brunzel

Product Details:

  • ISBN-10 ‏ : ‎ 1437709893
  • ISBN-13 ‏ : ‎ 978-1437709896
  • Author:  Nancy A. Brunzel

Renowned for its clear writing style, logical organization, level and depth of content, and excellent color illustrations, “Fundamentals of Urine & Body Fluid Analysis, 3rd Edition” covers the collection and analysis of urine, fecal specimens, vaginal secretions, and other body fluids such as cerebrospinal, synovial, seminal, amniotic, pleural, pericardial, and peritoneal fluids. Expert author Nancy Brunzel shares her extensive knowledge and expertise in the field, presenting key information and essential techniques and procedures, as well as easy-to-grasp explanations of how to correlate data with basic anatomy and physiology to understand pathological processes.

 

Table of Content:

  1. Chapter 1 Microscopy
  2. Learning Objectives
  3. Key Terms
  4. Brightfield Microscope
  5. FIGURE 1-1 A, A schematic representation of a brightfield microscope and its components. B, Path of illumination using Köhler illumination.
  6. FIGURE 1-2 Drawing depicting changes in numerical aperture. Note the increase in light angle (µ) attained and therefore in the numerical aperture when immersion oil is used.
  7. Eyepiece
  8. FIGURE 1-3 Schematic representation of a binocular eyepiece shows the location of the diopter adjustment ring.
  9. Mechanical Stage
  10. Condenser
  11. FIGURE 1-4 Schematic diagram of a condenser and an aperture diaphragm located beneath the mechanical stage of the microscope.
  12. FIGURE 1-5 Two types of aperture diaphragms. A, An iris diaphragm. B, A disk diaphragm.
  13. Illumination System
  14. Objectives
  15. FIGURE 1-6 Engravings on this objective indicate that it is a planachromat lens (SPlan); the initial magnification is 40×; the numerical aperture is 0.70; the objective is designed for a microscope with an optical tube length of 160 mm; and the coverslip thickness should be 0.17 ± 0.01 mm.
  16. Box 1-1 Binocular Microscope Adjustment Procedure With Köhler Illumination
  17. Preparing the Microscope
  18. Interpupillary Adjustment
  19. Diopter Adjustment
  20. Condenser Adjustment
  21. Condenser Height and Centration
  22. Field Diaphragm Adjustment
  23. Condenser Aperture Diaphragm Adjustment
  24. FIGURE 1-7 An illustration of chromatic aberration. Each wavelength of light is bent to a different focal point after passing through an uncorrected lens.
  25. FIGURE 1-8 An illustration of spherical aberration. Each light ray is bent toward a different focal point, depending on where the ray enters an uncorrected lens.
  26. Ocular Field Number
  27. Microscope Adjustment Procedure
  28. Care and Preventive Maintenance
  29. Box 1-2 Microscope Dos and Don’ts
  30. Dos
  31. Don’ts
  32. Types of Microscopy
  33. Brightfield Microscopy
  34. Phase-Contrast Microscopy
  35. FIGURE 1-9 The effect of the phase of light waves on the light intensity observed. A, All light waves are in phase, and light intensity is maximal. B, Some light waves are slower or are partially out of phase, resulting in a decrease in the light intensity observed. C, Equal numbers of light waves are in phase and out of phase. As a result, the net intensity observed is zero (i.e., the light waves cancel each other out).
  36. FIGURE 1-10 Schematic representation of (A) an annular diaphragm (placed below the condenser) and (B) the phase-shifting element (placed in back of the objective).
  37. FIGURE 1-11 Phase ring alignment. A schematic representation of the view at the back of the objective when one is looking down the eyepiece tube with the eyepiece removed. The dark annulus is formed by the phase-shifting element in the objective; the light annulus is formed by the annular diaphragm. Phase ring alignment is obtained by adjusting the light annulus until it is centered and superimposed on the dark annulus.
  38. FIGURE 1-12 An example of phase-contrast microscopy. This low-power (100×) view of urine sediment includes a highly refractile fiber revealed by its brightly haloed image. The hyaline casts and mucus threads are less refractile and have haloes of decreased intensity compared with the highly refractile fiber.
  39. FIGURE 1-13 Comparison of light ray orientation in (A) regular light (vibrating in all directions) and (B) polarized light (vibrating in only one plane).
  40. Polarizing Microscopy
  41. FIGURE 1-14 A, Schematic diagram of a polarizing microscope and its components. B, The change in the polarized light rays caused by a birefringent specimen. The polarizer and the analyzer are in a crossed position.
  42. Interference Contrast Microscopy
  43. FIGURE 1-15 An example of differential interference contrast (Nomarski) microscopy and its optical sectioning ability. The different plane of focus captured in each photomicrograph allows for greatly detailed imaging.
  44. Modulation Contrast Microscopy (Hoffman)
  45. FIGURE 1-16 Schematic representation of a modulation contrast microscope and its components.
  46. FIGURE 1-17 Example of the three-dimensional image produced by differential interference. This view shows a waxy cast at a magnification of 200×.
  47. Differential Interference Contrast Microscopy (Nomarski)
  48. Darkfield Microscopy
  49. FIGURE 1-18 Schematic representation of a differential interference contrast (Nomarksi) microscope and its components.
  50. FIGURE 1-19 Schematic representation of a darkfield microscope and its components.
  51. FIGURE 1-20 Schematic representation of a reflected illumination fluorescence microscope and its components.
  52. Fluorescence Microscopy
  53. TABLE 1-1 Comparison of Microscopic Capabilities
  54. Study Questions
  55. References
  56. Bibliography
  57. Chapter 2 Quality Assurance and Safety
  58. Learning Objectives
  59. Key Terms
  60. Quality Assurance
  61. Quality Assurance: What Is It?
  62. Preanalytical Components of Quality Assurance
  63. Table 2-1 Definitions and an Example of Policy for Handling Unlabeled or Mislabeled Specimens
  64. Box 2-1 Criteria for Urine Specimen Rejection
  65. Analytical Components of Quality Assurance
  66. Equipment
  67. Table 2-2 Urinalysis Equipment Performance Checks
  68. Reagents
  69. Procedure Manuals
  70. Box 2-2 Guidelines for Standardizing Microscopic Urinalysis
  71. Procedural Factors
  72. Reporting Factors
  73. Monitoring
  74. Monitoring Analytical Components of Quality Assurance
  75. Postanalytical Components of Quality Assurance
  76. Safety in the Urinalysis Laboratory
  77. Biological Hazards
  78. Table 2-3 Selected Evolution History of Isolation Precautions in Hospitals7,8
  79. Personal Protective Equipment
  80. FIGURE 2-1 The universal biohazard symbol.
  81. Specimen Processing
  82. Disposal of Waste
  83. Decontamination
  84. Chemical Hazards
  85. FIGURE 2-2 A, Label used by the Department of Transportation to indicate hazardous chemicals. B, The label identification system developed by the National Fire Protection Association.
  86. Handling Chemical Spills
  87. Disposal of Chemical Waste
  88. Other Hazards
  89. Study Questions
  90. Case 2-1
  91. Results
  92. References
  93. Bibliography
  94. Chapter 3 Urine Specimen Types, Collection, and Preservation
  95. Learning Objectives
  96. Key Terms
  97. Why Study Urine?
  98. Specimen Types
  99. First Morning Specimen
  100. Random Urine Specimen
  101. FIGURE 3-1 Urine as a fountain of information.
  102. TABLE 3-1 Urine Specimen Types
  103. Timed Collection
  104. Box 3-1 Timed Urine Collection Protocol
  105. Collection Techniques
  106. Routine Void
  107. Midstream “Clean Catch”
  108. Catheterized Specimen
  109. Suprapubic Aspiration
  110. TABLE 3-2 Urine Collection Techniques
  111. Pediatric Collections
  112. Box 3-2 Reasons for Urine Specimen Rejection
  113. Reasons for Urine Specimen Rejection
  114. Urine Volume Needed for Testing
  115. Urine Specimen Storage and Handling
  116. Containers
  117. Labeling
  118. Handling and Preservation
  119. Changes in Unpreserved Urine
  120. TABLE 3-3 Potential Changes in Unpreserved Urine
  121. Preservatives
  122. Timed Collections
  123. TABLE 3-4 Urine Preservatives*
  124. TABLE 3-5 Commercial Urine Transport Tubes With Preservative
  125. Is this Fluid Urine?
  126. Study Questions
  127. References
  128. Bibliography
  129. Chapter 4 The Kidney
  130. Learning Objectives
  131. Key Terms
  132. Renal Anatomy
  133. FIGURE 4-1 A schematic representation of the urinary tract. The relationship of the kidneys to the nephrons and the vascular system is shown.
  134. FIGURE 4-2 A diagram of a nephron.
  135. Renal Circulation
  136. Box 4-1 Outline of the Nephron and Its Components (As Used Throughout This Text)
  137. Glomerulus (or Renal Corpuscle)
  138. Tubules
  139. TABLE 4-1 Forces Involved in Glomerular Filtration
  140. FIGURE 4-3 The vascular circulation of a cortical and juxtamedullary nephron.
  141. Renal Physiology
  142. Urine Formation
  143. TABLE 4-2 Comparison of the Initial Ultrafiltrate and the Final Urine Composition of Selected Solutes per Day
  144. Glomerulus
  145. FIGURE 4-4 A schematic overview of a glomerulus. The afferent arteriole enters the glomerulus and the efferent arteriole exits the glomerulus at the vascular pole. Also at the vascular pole, a portion of the thick ascending limb of the distal tubule, the macula densa, is in contact with the glomerular mesangium. Bowman’s space is formed from specialized epithelial cells (Bowman’s capsule) at the end of a renal tubule. At the urinary pole, Bowman’s space becomes the tubular lumen of the proximal tubule. Podocytes are the epithelial cells that cover the glomerular capillaries and derive their name from their characteristic footlike processes. The glomerular capillaries are lined with fenestrated endothelial cells (i.e., epithelium with pores). The basement membrane, which separates the capillary endothelium and the podocytes (the epithelium of Bowman’s space), is continuous throughout the glomerulus. The basement membrane is absent between the capillary endothelium and the mesangium. The mesangial cells of the glomerular tuft form the structural core of the glomerulus and are continuous with the extraglomerular mesangial cells located at the vascular pole between the afferent and efferent arterioles. The secretory granules of the granular cells contain large amounts of renin. The afferent arteriole is innervated by sympathetic nerves.
  146. FIGURE 4-5 A scanning electron micrograph of the glomerular capillary endothelium as viewed from the capillary lumen. The openings or fenestrations of the endothelium resemble a dotted swiss pattern.
  147. FIGURE 4-6 A transmission electron micrograph of a glomerular filtration barrier. From left to right, capillary lumen (CL), fenestrated capillary endothelium, basement membrane, foot processes of podocytes separated by slit diaphragms, Bowman’s space, and portion of an overarching podocyte cell body (CB). The basement membrane consists of three distinct layers: the lamina rara interna (next to the capillary endothelium), the lamina densa, and the lamina rara externa (next to the epithelium or podocytes). The arrows indicate slit diaphragms that lie between the interdigitating foot processes.
  148. FIGURE 4-7 A scanning electron micrograph of podocytes and their interdigitating foot processes on glomerular capillaries as viewed from Bowman’s space. A, Epithelial or podocyte cell body (CB) and podocyte foot processes (P) on glomerular capillaries. B, An enlargement of interdigitating foot processes (F) of adjacent epithelial cells (podocyte). The arrows indicate primary processes and show the alternating pattern between epithelial cells.
  149. Tubules
  150. FIGURE 4-8 The general histologic characteristics of the renal tubular epithelium. Representative cross-sections of the various tubular segments roughly indicate their cellular morphology and the relative size of the cells, the tubules, and the tubular lumens.
  151. Tubular Function
  152. Transport
  153. FIGURE 4-9 A transmission electron micrograph of cross-sections of the medullary collecting duct epithelium. A, The intercellular spaces are narrow. B, The intercellular spaces are dilated. The observed dilation is probably due to the effect of antidiuretic hormone on the epithelium, enabling the passive reabsorption of water.
  154. Reabsorption
  155. Secretion
  156. TABLE 4-3 Summary of Tubular Reabsorption of Ultrafiltrate Components
  157. TABLE 4-4 Summary of Tubular Secretion of Important Ultrafiltrate Components
  158. Regulation of Acid-Base Equilibrium
  159. FIGURE 4-10 Hydrogen ion secretion and the mechanism of filtered bicarbonate reabsorption in the proximal tube. CA, Carbonic anhydrase.
  160. FIGURE 4-11 Hydrogen ion secretion and the formation of titratable acids. This is a mechanism of urine acidification in the collecting ducts. CA, Carbonic anhydrase.
  161. Tubular Transport Capacity
  162. FIGURE 4-12 Hydrogen ion secretion and the formation of ammonium ions. This is a mechanism of urine acidification in the collecting ducts. CA, Carbonic anhydrase; G, glutaminase.
  163. Proximal Tubular Reabsorption
  164. FIGURE 4-13 Tubular reabsorption of solutes and water in various segments of the nephron.
  165. Water Reabsorption
  166. Renal Concentrating Mechanism
  167. FIGURE 4-14 The countercurrent multiplier mechanism and the urea cycle maintain the hypertonicity of the medulla. A, In the loop of Henle, note that the fluid leaving the loop is slightly hypo-osmotic (100) compared with the fluid entering the loop (300). Numbers indicate osmolality in milliosmoles per kilogram H2O. B, Countercurrent mechanisms in an entire nephron. As H2O leaves the collecting duct (under antidiuretic hormone [ADH] regulation), the solutes become concentrated in the remaining filtrate, and osmolality increases. At the same time, a urea concentration gradient causes it to passively diffuse from the collecting duct into the interstitial fluid (IF) of the medulla. Some urea is eventually secreted back into the tubular lumen by the descending limb of the loop of Henle—the urea cycle (dashed line). The hypertonicity of the medulla enables the formation of hypertonic (concentrated) urine, with a maximum urine osmolality of 1200 to 1400 mOsm/kg (i.e., the same osmolality as is seen in the medullary interstitial fluid). Numbers indicate osmolality in milliosmoles per kilogram H2O.
  168. FIGURE 4-15 A schematic representation of the renin-angiotensin-aldosterone system and its role in the tubular reabsorption of sodium.
  169. FIGURE 4-16 A schematic representation of the mechanism controlling antidiuretic hormone secretion.
  170. TABLE 4-5 Tubular Lumen Fluid Osmolality* Throughout the Nephron
  171. Study Questions
  172. References
  173. Bibliography
  174. Chapter 5 Renal Function
  175. Learning Objectives
  176. Key Terms
  177. Urine Composition
  178. Solute Elimination
  179. TABLE 5-1 Composition of Selected Components in an Average 24-Hour Urine Collection
  180. Measurements of Solute Concentration
  181. Osmolality
  182. Specific Gravity
  183. FIGURE 5-1 A, Production of hypotonic urine. Hypotonic urine is produced by a nephron by the mechanism shown here. The isotonic (300 mOsm) tubule fluid that enters the Henle loop becomes hypotonic (100 mOsm) by the time it enters the distal convoluted tubule. The tubule fluid remains hypotonic as it is passes through remaining portions of the nephron, where the walls of the distal tubule and collecting duct are impermeable to H2O, Na+, and Cl−. Values are expressed in milliosmoles. B, Production of hypertonic urine. Hypertonic urine can be formed when antidiuretic hormone (ADH) is present. ADH, a posterior pituitary hormone, enables water reabsorption by the distal tubule and collecting duct. Thus hypotonic (100 mOsm) tubule fluid leaving the Henle loop can equilibrate first with the isotonic (300 mOsm) interstitial fluid (IF) of the cortex, then with the increasingly hypertonic (400 to 1200 mOsm) IF of the medulla. As H2O leaves the collecting duct by osmosis, the filtrate becomes more concentrated with the solutes left behind. The concentration gradient causes urea to diffuse into the IF, where some of it is eventually picked up by tubule fluid in the descending limb of the Henle loop (long arrow). This countercurrent movement of urea helps maintain a high solute concentration in the medulla. Values are expressed in milliosmoles.
  184. FIGURE 5-2 A comparison of urine specific gravity and urine osmolality. Specific gravity measurements were determined by a direct method (falling drop) and an indirect method (refractometry). The straight lines represent the specific gravity and osmolality results obtained with solutions of varying sodium chloride concentrations. A, A comparison of urines obtained from healthy medical students. B, A comparison of urines obtained from patients on renal service.
  185. TABLE 5-2 Comparison of Specific Gravities of Different Solutions
  186. Urine Volume
  187. FIGURE 5-3 A flowchart for the evaluation of polyuria. ADH, Antidiuretic hormone; U/S, urine-to-serum osmolality ratio.
  188. Box 5-1 Differentiation of Polyuria
  189. Assessment of Renal Concentrating Ability/Tubular Reabsorptive Function
  190. Osmolality Versus Specific Gravity
  191. Fluid Deprivation Tests
  192. Osmolar and Free-Water Clearance
  193. Assessment of Glomerular Filtration
  194. Renal Clearance
  195. Clearance Tests
  196. Inulin Clearance
  197. Creatinine Clearance
  198. FIGURE 5-4 The formation of creatinine from creatine and phosphocreatine. ADP, Adenosine diphosphate; ATP, adenosine triphosphate.
  199. TABLE 5-3 Variation in Reference Intervals for Serum Creatinine and Creatinine Clearance According to Age and Gender*
  200. Advantages and Disadvantages
  201. Importance of Time Interval
  202. Box 5-2 Creatinine Clearance
  203. Example
  204. Discussion
  205. Alternate Approaches to Assessing Glomerular Filtration Rate
  206. Estimated GFR (eGFR)
  207. Equation 5-7 Original
  208. Equation 5-8 IDMS–traceable
  209. β2-Microglobulin and Cystatin C
  210. Screening for Albuminuria
  211. Assessment of Renal Blood Flow and Tubular Secretory Function
  212. Determination of Renal Plasma Flow and Renal Blood Flow
  213. Assessment of Tubular Secretory Function for Acid Removal
  214. Measurement of Titratable Acid Versus Urinary Ammonia
  215. Oral Ammonium Chloride Test
  216. Study Questions
  217. Case 5-1
  218. Patient Information
  219. Case 5-2
  220. Results
  221. References
  222. Bibliography
  223. Chapter 6 Physical Examination of Urine
  224. Learning Objectives
  225. Key Terms
  226. Color
  227. TABLE 6-1 Urine Color Terms and Common Causes*
  228. TABLE 6-2 Urine Color Changes With Some Commonly Used Drugs
  229. Box 6-1 Recommendations for the Evaluation of Urine Physical Characteristics
  230. Foam
  231. FIGURE 6-1 A, Distinctive coloration of urine foam due to the high bilirubin concentration in the urine specimen. B, Large amount of urine foam due to a high concentration of protein, specifically albumin, in the urine specimen.
  232. Clarity
  233. TABLE 6-3 Clarity Terms
  234. Box 6-2 Classification of Substances Causing Urine Turbidity
  235. Odor
  236. TABLE 6-4 Causes of Urine Odors
  237. Taste
  238. Concentration
  239. Specific Gravity
  240. Urinometry
  241. FIGURE 6-2 A urinometer (hydrometer).
  242. FIGURE 6-3 A schematic diagram illustrates the refraction (or bending) of light as it passes from one medium to another of differing density. The velocity of the light beam also changes.
  243. Harmonic Oscillation Densitometry
  244. Refractometry
  245. FIGURE 6-4 A refractometer with the pathway of light superimposed.
  246. TABLE 6-5 Calibration Solutions for Refractometry
  247. Reagent Strip Method
  248. FIGURE 6-5 A schematic representation of the viewing field and scale in the refractometer.
  249. Equation 6-3
  250. SG Result Discrepancies Between Reagent Strip and Refractometry
  251. Osmolality
  252. TABLE 6-6 Urine Concentration Assessment: Specific Gravity and Osmolality
  253. Freezing Point Osmometry
  254. FIGURE 6-6 A time-temperature curve during freezing point depression osmometry.
  255. Vapor Pressure Osmometry
  256. Volume
  257. TABLE 6-7 Urine Volume Terms, Definitions, and Clinical Correlations
  258. Study Questions
  259. Case 6-1
  260. Case 6-2
  261. References
  262. Bibliography
  263. Chapter 7 Chemical Examination of Urine
  264. Learning Objectives
  265. Key Terms
  266. Reagent Strips
  267. FIGURE 7-1 A commercial reagent strip or dipstick consists of reagent-impregnated test pads that are fixed to an inert plastic strip. After the strip has been appropriately wetted in a urine sample, chemical reactions cause the reaction pads to change color. At the appropriate “read time,” results are determined by comparing the color of each reaction pad with the appropriate analyte on the color chart.
  268. TABLE 7-1 Comparison of Reagent Strip Principles
  269. Care and Storage
  270. Quality Control Testing
  271. Tablet and Chemical Tests
  272. Care and Storage
  273. Quality Control Testing
  274. Chemical Testing Technique
  275. Reagent Strips
  276. Box 7-1 Appropriate Manual Reagent Strip Testing Technique
  277. TABLE 7-2 Comparison of the Sensitivity and Specificity of Reagent Strips
  278. Tablet and Chemical Tests
  279. Chemical Tests
  280. Specific Gravity
  281. Clinical Significance
  282. Principle
  283. Box 7-2 Clinical Significance of Urine Specific Gravity Results
  284. pH
  285. Clinical Significance
  286. TABLE 7-3 Clinical Correlation of Urine pH Values
  287. Methods
  288. Reagent Strip Tests
  289. pH Meter
  290. pH Test Papers
  291. Blood
  292. Clinical Significance
  293. Hematuria and Hemoglobinuria
  294. Box 7-3 Clinical Significance of Positive Blood Reaction
  295. TABLE 7-4 Comparison of Selected Urine and Plasma Components in Mild and Severe Hemolytic Episodes
  296. Myoglobinuria
  297. Differentiation of Hemoglobinuria and Myoglobinuria
  298. TABLE 7-5 Differentiation of Hemoglobinuria and Myoglobinuria
  299. Method
  300. Leukocyte Esterase
  301. Clinical Significance
  302. Box 7-4 Diagnostic Utility of Positive Leukocyte Esterase Reaction
  303. Methods
  304. Nitrite
  305. Clinical Significance
  306. Methods
  307. Box 7-5 Diagnostic Utility of Nitrite* Reaction
  308. Protein
  309. Clinical Significance
  310. Box 7-6 Classification of Proteinuria
  311. Box 7-7 Principal Proteins in Glomerular Proteinuria
  312. Box 7-8 Principal Proteins in Tubular Proteinuria
  313. Methods
  314. TABLE 7-6 Characterization of Renal Proteinuria
  315. Sulfosalicylic Acid Precipitation Test
  316. Reagent Strip Tests
  317. TABLE 7-7 Sulfosalicylic Acid Precipitation Grading Guideline
  318. TABLE 7-8 Comparison of Reagent Strip and SSA Protein Test Results
  319. Sensitive Albumin Tests
  320. TABLE 7-9 Sensitive Albumin (Microalbumin) Tests
  321. Glucose
  322. Clinical Significance
  323. Box 7-9 Presentations of Glucosuria and Associated Disorders
  324. FIGURE 7-2 A schematic diagram comparing the filtration and reabsorption of glucose by proximal tubular cells normally and in conditions of hyperglycemia and renal tubular disease.
  325. FIGURE 7-3 A series of albumin standards analyzed using the sulfosalicylic acid precipitation test.
  326. Box 7-10 Diagnostic Utility of Urine Glucose Testing
  327. Methods
  328. Reagent Strip Tests
  329. Copper Reduction Tests
  330. FIGURE 7-4 A, A series of glucose standards analyzed using the Clinitest 2-drop method. Note that the tube with greater than 5000 mg/dL glucose has demonstrated the “pass-through” effect (i.e., after reaction, the mixture returns to a greenish color). B, Clinitest color charts. Note the subtle differences between the 5-drop and 2-drop color charts. It is essential that reaction mixtures be compared with the proper color chart to obtain accurate results. Do not use these color charts for diagnostic testing.
  331. Box 7-11 Reducing Substances in Urine That Cause Copper Reduction Tests
  332. Comparison of the Clinitest Method and Glucose Reagent Strip Tests
  333. TABLE 7-10 Comparison of the Glucose Reagent Strip Test and the Clinitest Tablet Test
  334. Ketones
  335. Formation
  336. Clinical Significance
  337. FIGURE 7-5 The formation of ketones from fatty acid metabolism. ATP, Adenosine triphosphate; CoA, coenzyme A; SCoA, succinyl coenzyme A.
  338. Box 7-12 Causes of Ketonuria
  339. Methods
  340. Reagent Strip Tests
  341. Nitroprusside Tablet Test for Ketones (Acetest)
  342. Bilirubin and Urobilinogen
  343. Formation
  344. FIGURE 7-6 A, A positive Acetest for ketones. B, An Acetest color chart. Do not use this color chart for diagnostic testing.
  345. FIGURE 7-7 A schematic diagram of hemoglobin catabolism.
  346. Clinical Significance
  347. TABLE 7-11 Diagnostic Utility of Urine Bilirubin, Urobilinogen, and Fecal Color
  348. Bilirubin Methods
  349. Physical Examination
  350. Reagent Strip Tests for Bilirubin
  351. FIGURE 7-8 Bilirubin metabolism and alterations in normal metabolism caused by disease. A, Normal bilirubin metabolism. B, Prehepatic alteration of bilirubin metabolism. C, Hepatic alteration of bilirubin metabolism. D, Posthepatic alteration of bilirubin metabolism.
  352. Diazo Tablet Test for Bilirubin (Ictotest Method)
  353. FIGURE 7-9 A, A negative Ictotest. B, A positive Ictotest for bilirubin. C, A negative Ictotest showing an atypical color.
  354. Urobilinogen Methods
  355. Box 7-13 Some Ehrlich’s Reactive Substances Found in Urine
  356. Classic Ehrlich’s Reaction
  357. Reagent Strip Tests for Urobilinogen
  358. Multistix Reagent Strips
  359. Equation 7-16 Ehrlich’s Reaction
  360. Chemstrip and vChem Reagent Strips
  361. FIGURE 7-10 A schematic diagram of heme synthesis.
  362. Porphobilinogen
  363. Clinical Significance
  364. Methods
  365. Physical Examination
  366. Hoesch Test for Porphobilinogen
  367. FIGURE 7-11 The Hoesch test (urine + reagent) before the tube is mixed. A, A negative test. B, A positive test.
  368. Watson-Schwartz Test for Porphobilinogen and Urobilinogen
  369. Equation 7-19
  370. Equation 7-20
  371. TABLE 7-12 Watson-Schwartz Test Result Summary
  372. FIGURE 7-12 A, A positive Ehrlich’s reaction, which indicates the presence of an Ehrlich reactive substance in the urine. B, A modified Watson-Schwartz test using the same urine: tube 1 is the chloroform extraction; tube 2 is the butanol extraction. The test is positive for porphobilinogen.
  373. Ascorbic Acid
  374. Clinical Significance
  375. FIGURE 7-13 Ascorbic acid. The highlighted ene-diol group of ascorbic acid is responsible for its strong reducing ability (i.e., as a hydrogen donator). Normally, the principal metabolite of ascorbic acid—oxalate—accounts for approximately 50% of the urinary oxalate excreted daily.
  376. Mechanisms of Interference
  377. TABLE 7-13 False Negative or Decreased Reagent Strip Results Due to Ascorbic Acid Interference
  378. Method
  379. Equation 7-21
  380. TABLE 7-14 Findings That Can Initiate Reflex Testing
  381. Reflex Testing and Result Correlation
  382. TABLE 7-15 Correlation Between Chemical and Microscopic Examinations
  383. TABLE 7-16 Typical Reference Intervals for Chemical Examination of Urine*
  384. Study Questions
  385. Case 7-1
  386. Results
  387. Case 7-2
  388. Results
  389. Case 7-3
  390. Results
  391. Case 7-4
  392. Serum Chemistry Results
  393. Urine Results
  394. Case 7-5
  395. Chemistry Results
  396. Results
  397. Case 7-6
  398. Results
  399. References
  400. Bibliography
  401. Chapter 8 Microscopic Examination of Urine Sediment
  402. Learning Objectives
  403. Key Terms
  404. Standardization of Sediment Preparation
  405. TABLE 8-1 Factors That Require Standardization in the Microscopic Examination
  406. TABLE 8-2 Comparison of Selected Standardized Urinalysis Systems
  407. Commercial Systems
  408. FIGURE 8-1 A commercial urine sediment preparation system. The KOVA System consists of a KOVA tube (2), a KOVA Pettor (3), and a KOVA cap (1). The clear plastic centrifuge tube is filled to the appropriate graduation mark with well-mixed urine and is capped. After centrifugation, the specially designed KOVA Pettor is gently slid into the tube, and the end is firmly seated into the base (4). The bulblike end fits snuggly, such that all but 1 mL of urine can be easily decanted (red arrow). The retained supernatant urine is used to resuspend the sediment for the microscopic examination.
  409. Specimen Volume
  410. FIGURE 8-2 The rotor radius (R) is the distance measured from the rotor’s axis of rotation to the bottom of the specimen tube at its greatest horizontal distance from the rotor axis. A, The radius when a horizontal rotor is used. B, The radius when a fixed-angle rotor is used.
  411. Centrifugation
  412. Sediment Concentration
  413. Volume of Sediment Viewed
  414. FIGURE 8-3 Commercial microscope slides. A, A 10-position UriSystem slide with integrated coverslips. B, A plastic 10-chamber KOVA Glasstic slide.
  415. Reporting Formats
  416. TABLE 8-3 Qualitative Terms and Descriptions for Fields of View (FOVs)
  417. Box 8-1 Conversion of the Number of Formed Elements Present in a Microscopic Field to the Number of Formed Elements Present in a Volume of Urine
  418. TABLE 8-4 Visualization Techniques to Aid in the Microscopic Examination of Urine Sediment
  419. Enhancing Urine Sediment Visualization
  420. Staining Techniques
  421. Supravital Stains
  422. FIGURE 8-4 Two squamous epithelial cells stained with Sternheimer-Malbin stain. Brightfield, 100×.
  423. FIGURE 8-5 Fragment of renal collecting duct epithelial cells stained with 0.5% toluidine blue. Brightfield, 400×.
  424. FIGURE 8-6 Leukocytes stained with 0.5% toluidine blue. Brightfield, 400×.
  425. FIGURE 8-7 Oval fat body stained with Sudan III stain. Note the characteristic orange-red coloration of neutral fat globules. Brightfield, 400×.
  426. Acetic Acid
  427. Fat or Lipid Stains
  428. Gram Stain
  429. FIGURE 8-8 Bacteria. Gram stain of gram-negative rods and gram-positive cocci. Brightfield, 1000×.
  430. FIGURE 8-9 Eosinophil (arrow) in urine stained with Hansel stain. Cytospin, 400×.
  431. Prussian Blue Reaction
  432. Hansel Stain
  433. FIGURE 8-10 Waxy cast. A, Brightfield, 100×. B, Phase contrast, 100×. Note the central fissure and increased detail revealed using phase-contrast microscopy.
  434. Microscopy Techniques
  435. Phase-Contrast Microscopy
  436. Polarizing Microscopy
  437. FIGURE 8-11 A, Cholesterol droplets displaying their characteristic Maltese cross pattern using polarizing microscopy, 400×. B, Polarizing microscopy with a first-order red compensator plate, 400×.
  438. Interference Contrast Microscopy
  439. FIGURE 8-12 Three-dimensional image of the waxy cast in Figure 8-7 using differential interference contrast (Nomarski) microscopy, 100×. Compare images obtained in these two figures.
  440. Cytocentrifugation and Cytodiagnostic Urinalysis
  441. Cytocentrifugation
  442. Cytodiagnostic Urinalysis
  443. Formed Elements in Urine Sediment
  444. TABLE 8-5 Reference Intervals for Microscopic Examination*
  445. Blood Cells
  446. Red Blood Cells (Erythrocytes)
  447. Microscopic Appearance
  448. FIGURE 8-13 Three red blood cells: Two viewed from above appear as biconcave disks, and one viewed from the side appears hourglass-shaped (arrows). Also present are budding yeast and several white blood cells. Brightfield, Sedi-Stain, 400×.
  449. FIGURE 8-14 Dysmorphic and crenated red blood cells. A single ghost red blood cell is located at top of view. Phase contrast, 400×.
  450. Correlation With Physical and Chemical Examinations
  451. TABLE 8-6 Red Blood Cells: Microscopic Features and Correlations
  452. Look-Alikes
  453. Clinical Significance
  454. White Blood Cells (Leukocytes)
  455. Neutrophils
  456. Microscopic Appearance
  457. FIGURE 8-15 Several white blood cells with characteristic cytoplasmic granules and lobed nuclei surrounding a squamous epithelial cell. Budding yeast cells are also present. Brightfield, Sedi-Stain, 400×.
  458. FIGURE 8-16 A clump of white blood cells. One red blood cell and budding yeast are also present. Brightfield, Sedi-Stain, 400×.
  459. FIGURE 8-17 Disintegrating white blood cells with the formation of blebs. Phase contrast, 400×.
  460. FIGURE 8-18 Formation of myelin filaments in disintegrating white blood cells. Phase contrast, 400×.
  461. Correlation With Physical and Microscopic Examinations
  462. Look-Alikes
  463. TABLE 8-7 White Blood Cells (WBCs): Microscopic Features and Correlations
  464. Clinical Significance
  465. Eosinophils
  466. FIGURE 8-19 Two renal collecting duct cells stained with 0.5% toluidine blue. Their polygonal shape and nuclear detail distinguish them from leukocytes. Brightfield, 400×.
  467. FIGURE 8-20 Eosinophil (arrow) in a cytospin of urine stained with Hansel stain. Brightfield, 400×.
  468. FIGURE 8-21 Lymphocyte (arrow) in a cytospin of urine sediment. Brightfield, 400×.
  469. Lymphocytes
  470. Monocytes and Macrophages (Histiocytes)
  471. FIGURE 8-22 Macrophages and several other white blood cells. A, Brightfield, 400×. B, Brightfield, Sedi-Stain, 400×.
  472. Epithelial Cells
  473. FIGURE 8-23 Oval fat body. A cell with numerous highly refractile fat globules and other inclusions. Brightfield, 400×.
  474. TABLE 8-8 Epithelial Cells: Microscopic Features and Clinical Significance
  475. FIGURE 8-24 Squamous epithelial cells: one large clump and several individual cells. Note their large, thin, flagstone-shaped appearance, centrally located nuclei, and stippled cytoplasm (stippling increases with cellular degeneration). A few ribbon-like mucous threads are also present. Phase contrast, 100×.
  476. Squamous Epithelial Cells
  477. FIGURE 8-25 Two squamous epithelial cells. The cell on the left is presenting a side view, demonstrating how flat these cells are. The upper edge of the cell on the right is curled, producing an unusual form. A, Brightfield, Sedi-Stain, 200×. B, Phase contrast, 200×.
  478. Transitional (Urothelial) Epithelial Cells
  479. FIGURE 8-26 Two transitional (urothelial) epithelial cells. A, Phase contrast, 400×. B, Interference contrast, 400×.
  480. FIGURE 8-27 Four transitional (urothelial) epithelial cells. Phase contrast, 400×.
  481. Renal Tubular Epithelial Cells
  482. Convoluted Renal Tubular Cells
  483. Proximal Convoluted Tubular Cells
  484. Distal Convoluted Tubular Cells
  485. FIGURE 8-28 Convoluted tubular epithelial cells. A, Numerous proximal convoluted tubular cells. Note the similarity in shape to granular casts and that their nuclei are not readily apparent in many cells. Phase contrast, 200×. B, Sediment stained with 0.5% toluidine blue. A large, castlike proximal tubular cell and a smaller, round distal tubular cell are present with two hyaline casts and other debris. Brightfield, 400×. C, A single proximal tubular cell stained with 0.5% toluidine blue. Note the indistinct cell margins, granular cytoplasm, and small eccentric nucleus. Brightfield, 400×.
  486. FIGURE 8-29 Renal collecting duct epithelial cells. A, Two cells with an intact edge. Brightfield, toluidine blue stain, 400×. B, A single cell. Interference contrast, 400×.
  487. Collecting Duct Cells
  488. FIGURE 8-30 A, Fragment of renal collecting duct epithelial cells. Brightfield, 400×. B, Fragment of renal collecting duct epithelial cells in “spindle” form, indicative of regeneration of the tubular epithelium after injury. Interference contrast, 400×.
  489. Renal Tubular Cells With Absorbed Fat
  490. FIGURE 8-31 Oval fat body. Note the size variation of the fat globules. Brightfield, 400×.
  491. Casts
  492. Formation and General Characteristics
  493. FIGURE 8-32 Three hyaline casts and several mucous threads. Phase contrast, 100×.
  494. FIGURE 8-33 Three hyaline casts. The cast with a tapered end is frequently called a cylindroid. Phase contrast, 100×.
  495. FIGURE 8-34 Two broad, granular to waxy casts. A, Brightfield, 100×. B, Interference contrast, 100×.
  496. FIGURE 8-35 Convoluted hyaline cast, initially formed in a tubule and later compressed in a tubule of larger diameter. Phase contrast, 200×.
  497. FIGURE 8-36 Coarsely granular going to waxy cast. Brightfield, 100×.
  498. FIGURE 8-37 One intact finely granular/waxy cast and two broken pieces of a cast. Brightfield, 100×.
  499. Clinical Significance
  500. FIGURE 8-38 A low-power field of view revealing casts of various types: cellular, granular, and mixed. Brightfield, Sedi-Stain, 100×.
  501. Classification of Casts
  502. Box 8-2 Classification of Urinary Casts
  503. Homogeneous Matrix Composition
  504. Hyaline Casts
  505. FIGURE 8-39 Hyaline casts. Three hyaline casts and mucous threads. Brightfield, 200×.
  506. FIGURE 8-40 Hyaline cast. Note the appearance of the fibrillar protein matrix and the presence of fine granulation. Phase contrast, 400×.
  507. Waxy Casts
  508. TABLE 8-9 Casts: Microscopic Features and Correlations
  509. FIGURE 8-41 Waxy cast. A, Brightfield, 100×. B, Interference contrast, 100×.
  510. FIGURE 8-42 Cast, part granular and part waxy. Note the difference in cast diameter at one end compared with the other. This indicates initial cast formation in a narrow tubular lumen followed by stasis in a tubule with a wider lumen and further cast formation. A, Brightfield, Sedi-Stain, 200×. B, Interference contrast, 200×.
  511. Cellular Inclusion Casts
  512. Red Blood Cell Casts
  513. FIGURE 8-43 Red blood cell cast. Red blood cells are embedded in the cast matrix. Brightfield, 400×.
  514. FIGURE 8-44 A pigmented granular cast or blood cast. The granules and pigmentation originate from hemoglobin and red blood cell degeneration. Brightfield, 200×.
  515. FIGURE 8-45 Red blood cell cast. This cast is packed with intact red blood cells. A, Brightfield, 200×. B, Interference contrast, 400×.
  516. FIGURE 8-46 White blood cell cast. Brightfield, 400×.
  517. White Blood Cell Casts
  518. FIGURE 8-47 Renal tubular cell cast. Brightfield, 200×.
  519. Renal Tubular Cell Casts
  520. FIGURE 8-48 Two casts, one hyaline, the other with coarsely granular inclusions. Brightfield, 200×.
  521. Mixed Cell Casts
  522. Bacterial Casts
  523. Casts With Inclusions
  524. Granular Casts
  525. FIGURE 8-49 Finely granular and coarsely granular casts. Pigmentation from hemoglobin degradation. Brightfield, 200×.
  526. Fatty Casts
  527. FIGURE 8-50 A fatty cast. Note the globules and their characteristic refractility. Brightfield, 400×.
  528. FIGURE 8-51 Fatty cast. Note the high refractility of the fat globule inclusions in the matrix of the cast. A, Phase contrast, 400×. B, Polarizing microscopy, 400×. The highly refractile fat globules apparent in A do not exhibit a Maltese cross pattern, identifying them as neutral fat; those with a Maltese cross pattern are cholesterol.
  529. FIGURE 8-52 Cast with sulfamethoxazole crystal inclusions. Brightfield, 200×.
  530. Other Inclusion Casts
  531. Pigmented Casts
  532. FIGURE 8-53 Cast with monohydrate calcium oxalate crystal inclusions. A, Brightfield, 400×. B, Polarizing microscopy with first-order red compensator, 400×.
  533. Size
  534. Correlation With Physical and Chemical Examinations
  535. FIGURE 8-54 Pigmented granular cast. A, Brightfield, 200×. B, Phase contrast, 200×. Note the enhanced visualization of low-refractile components such as the hyaline matrix and mucus using phase-contrast microscopy.
  536. FIGURE 8-55 Bile-stained cellular cast. Brightfield, 200×.
  537. FIGURE 8-56 Broad waxy cast and numerous hyaline casts. Brightfield, 200×.
  538. Look-Alikes
  539. FIGURE 8-57 A, Diaper fiber demonstrating anisotropism (strong birefringence) with polarizing microscopy, 200×. B, Polarizing microscopy with first-order red compensator, 200×.
  540. Crystals
  541. Contributing Factors
  542. Acidic Urine
  543. Amorphous Urates
  544. TABLE 8-10 Crystals of Normal Urine Solutes Arranged According to pH
  545. TABLE 8-11 Abnormal Crystals of Metabolic and Iatrogenic* Origin Arranged According to pH
  546. FIGURE 8-58 Amorphous urates. A, Two uric acid crystals are also present. Brightfield, 400×. B, Polarizing microscopy, 400×.
  547. FIGURE 8-59 Acid urate crystals. Brightfield, 200×.
  548. FIGURE 8-60 Monosodium urate crystals. Brightfield, 200×.
  549. Acid Urates
  550. Monosodium Urate
  551. Uric Acid
  552. FIGURE 8-61 Uric acid crystals (diamond-shaped) and a few calcium oxalate crystals. Note the darker coloration as the crystals layer and thicken. Brightfield, 200×.
  553. FIGURE 8-62 Uric acid crystals. Single and cluster forms. Brightfield, 200×.
  554. FIGURE 8-63 Uric acid crystals. Less common barrel forms. Brightfield, 200×.
  555. FIGURE 8-64 Uric acid crystals. Barrel form. Brightfield, 200×.
  556. FIGURE 8-65 Uric acid crystals. These crystals can layer or laminate on top of one another. Brightfield, 100×.
  557. Calcium Oxalate
  558. FIGURE 8-66 Calcium oxalate crystals. Octahedral (envelope) form of dihydrate crystals. Brightfield, 200×.
  559. FIGURE 8-67 Calcium oxalate crystals. An unusual barrel form and a typical dehydrate form. Brightfield, 400×.
  560. FIGURE 8-68 Calcium oxalate crystals. Small ovoid monohydrate crystals that resemble erythrocytes, and two large typical envelope forms of dihydrate crystals. A, Brightfield, 400×. B, Polarizing microscopy, 400×. The birefringence of these small ovoid crystals helps distinguish them from erythrocytes.
  561. Alkaline Urine
  562. Amorphous Phosphate
  563. FIGURE 8-69 Amorphous phosphates. Note the lack of birefringence under polarizing microscopy. A, Brightfield microscopy, 400×. B, Polarizing microscopy with first-order red compensator, 400×.
  564. FIGURE 8-70 Triple phosphate crystals. Typical “coffin lid” form. Brightfield, 100×.
  565. Triple Phosphate
  566. FIGURE 8-71 Calcium phosphate crystals. Prisms are arranged singly and in rosette forms. Brightfield, 100×.
  567. Calcium Phosphate
  568. FIGURE 8-72 Calcium phosphate crystals. Uncommon slender needles arranged in bundles or sheaves. Other crystals present in background include ammonium biurate, calcium carbonate, and a single calcium oxalate. Brightfield, 400×.
  569. FIGURE 8-73 Calcium phosphate sheet or plate. Brightfield, 100×.
  570. Magnesium Phosphate
  571. FIGURE 8-74 Magnesium phosphate crystals. Brightfield, 400×.
  572. FIGURE 8-75 Ammonium biurate crystals. Spheres and a “thorny apple” form. Brightfield, 200×.
  573. FIGURE 8-76 Ammonium biurate crystals. Several “thorny apple” forms. Brightfield, 200×.
  574. Ammonium Biurate
  575. Calcium Carbonate
  576. FIGURE 8-77 Calcium carbonate. A, Numerous single crystals. Brightfield, 400×. B, Aggregate of calcium carbonate crystals. Brightfield, 400×.
  577. Crystals of Metabolic Origin
  578. Bilirubin
  579. Cystine
  580. FIGURE 8-78 Bilirubin crystal. Brightfield, 400×.
  581. Tyrosine and Leucine
  582. FIGURE 8-79 Cystine crystals. Brightfield, 400×.
  583. Cholesterol
  584. FIGURE 8-80 Tyrosine crystals. Brightfield, 400×.
  585. FIGURE 8-81 A, View of urine sediment with a cholesterol crystal, free-floating fat, and oval fat bodies. Brightfield, 200×. B, Cholesterol crystal. Phase contrast, 400×.
  586. FIGURE 8-82 Radiographic contrast medium, meglumine diatrizoate (Renografin). The crystals appear as plates. Brightfield, 100×. Compare with cholesterol crystals (intravenous administration), Figure 8-71.
  587. Crystals of Iatrogenic Origin
  588. Medications
  589. FIGURE 8-83 Ampicillin crystals. Brightfield, 400×.
  590. Ampicillin
  591. Indinavir
  592. Sulfonamides
  593. FIGURE 8-84 Indinavir sulfate crystals. A, Brightfield, 200×. B, Polarizing microscopy with first-order red compensator, 200×.
  594. FIGURE 8-85 Sulfadiazine crystals. Brightfield, 400×.
  595. FIGURE 8-86 Sulfamethoxazole (Bactrim) crystals. Brightfield, 400×.
  596. FIGURE 8-87 Radiographic contrast medium following retrograde administration; meglumine diatrizoate (Renografin). The crystals appear in needle forms. Brightfield, 100×.
  597. Radiographic Contrast Media
  598. Microorganisms in Urine Sediment
  599. Bacteria
  600. FIGURE 8-88 Intravenous radiographic contrast medium. A, Interference contrast microscopy, 100×. B, Polarizing microscopy, 100×.
  601. Yeast
  602. FIGURE 8-89 Urine sediment with bacteria (rods), two erythrocytes, and a leukocyte. Phase contrast, 400×.
  603. TABLE 8-12 Microorganismsin Urine Sediment
  604. FIGURE 8-90 Budding yeast and pseudohyphae. Leukocytes are also present singly and as a clump. Brightfield, Sedi-Stain, 400×.
  605. FIGURE 8-91 Pseudohyphae development by yeast. A, Interference contrast, 400×. B, Brightfield, 400×.
  606. FIGURE 8-92 Leukocytes with intracellular yeast. Interference contrast, 400×.
  607. Trichomonas Vaginalis
  608. FIGURE 8-93 Schematic diagram of Trichomonas vaginalis.
  609. FIGURE 8-94 A trichomonad in urine sediment. Because of their rapid flitting motion, only one of the flagella is visible in this view (arrow). Mucus, white blood cells, and other trichomonads are present but are not in focus at this focal plane. Phase contrast, 400×.
  610. Clue Cells and Gardnerella Vaginalis
  611. FIGURE 8-95 The slightly larger squamous epithelial cell with indistinct, shaggy cytoplasmic edges is a clue cell. The cell with well-defined cytoplasmic edges is a normal squamous epithelial cell. A, Brightfield, 200×. B, Phase contrast, 200×.
  612. Parasites
  613. FIGURE 8-96 An Enterobius vermicularis egg, unstained wet mount. Note its oval shape with a slightly flattened side and the developing larva within.
  614. Miscellaneous Formed Elements
  615. Mucus
  616. FIGURE 8-97 Cysts of Giarda lamblia. A, A single Giardia lamblia cyst, unstained. B, Two Giardia lamblia cysts, trichrome stained.
  617. Fat
  618. FIGURE 8-98 A Schistosoma haematobium egg, unstained wet mount Note the terminal spine on this large, American football shaped egg.
  619. FIGURE 8-99 Mucus. A, Several mucous threads and two hyaline casts. Phase contrast, 100×. B, A mass of mucus surrounding a fiber (contaminant). Brightfield, 400×.
  620. FIGURE 8-100 Chemical structures of triglyceride (triacylglycerol or neutral fat), cholesterol, and cholesterol esters.
  621. FIGURE 8-101 Three oval fat bodies stained with Sudan III stain. Note the characteristic orange-red staining of neutral fat globules. Brightfield, 400×.
  622. FIGURE 8-102 Cholesterol droplets demonstrating the characteristic Maltese cross pattern. Polarizing microscopy with first-order red compensator, 400×.
  623. Hemosiderin
  624. Sperm
  625. FIGURE 8-103 A, Hemosiderin granules floating free in urine sediment. Brightfield, 400×. B, Hemosiderin granules after staining with Prussian blue. Brightfield, 400×.
  626. FIGURE 8-104 Spermatozoa in urine sediment. One typical and two atypical forms. Phase contrast, 400×.
  627. FIGURE 8-105 Hyaline cast and a fiber. Note the difference in form and refractility. A, Brightfield, 100×. B, Phase contrast, 100×.
  628. Contaminants
  629. Fibers
  630. Starch
  631. FIGURE 8-106 Starch granules. Brightfield, 400×.
  632. FIGURE 8-107 Starch granules. A, Demonstration of a Maltese cross pattern using polarizing microscopy, 400×. B, Polarizing microscopy with first-order red compensator, 400×.
  633. FIGURE 8-108 Charcoal granules (arrows) in urine sediment. Numerous leukocytes are present. Cytospin preparation, Wright’s stain, brightfield microscopy, 400×.
  634. Fecal Matter
  635. Correlation of Urine Sediment Findings With Disease
  636. TABLE 8-13 Urine Sediment Findings With Selected Diseases
  637. Study Questions
  638. Case 8-1
  639. Results
  640. Case 8-2
  641. Results
  642. Case 8-3
  643. Results
  644. Case 8-4
  645. Results
  646. Case 8-5
  647. Results
  648. Case 8-6
  649. Results
  650. Case 8-7
  651. Results
  652. References
  653. Bibliography
  654. Urine Sediment Image Gallery
  655. Artifacts/Contaminants
  656. FIGURE 1 Three air bubbles trapped beneath a coverslip observed using low-power (100×) magnification. Numerous white blood cells (WBCs) are also present.
  657. FIGURE 2 A diaper fiber. Note its flat, wrinkled appearance and strong refractility. For an inexperienced microscopist, these fibers may be misidentified as waxy casts.
  658. FIGURE 3 A clothing fiber. Its refractility, frayed ends, and flatness aid in its proper identification.
  659. FIGURE 4 A starch granule (black arrow) demonstrating a characteristic dimple. When glass slides and coverslips are used, glass fragments (red arrows) can be present. Numerous white blood cells are also present.
  660. FIGURE 5 When plastic commercial standardized slides are used, fragments of plastic (red arrows) can be present in the sediment. Red blood cells, yeasts, and pseudohyphae are also present.
  661. FIGURE 6 Three starch granules, all highly refractile, with slightly differing appearances, yet each has a centrally located dimple. Fragments of plastic (red arrows) are also present.
  662. Blood Cells
  663. Red Blood Cells
  664. FIGURE 7 Numerous intact and ghost red blood cells (black arrows). In this image, intact cells have a characteristic appearance caused by the hemoglobin within them. In contrast, ghost red blood cells (RBCs) have intact cell membranes but have lost their hemoglobin. This urine was hypotonic (dilute; low specific gravity), and many of the RBCs appear swollen and rounded because of the diffusion of fluid into the cells.
  665. FIGURE 8 Red blood cells in hypertonic urine (concentrated; high specific gravity). Many of the cells in this field of view have lost their typical biconcave shape and are crenated. This happens when fluid within the cell is transferred into the urine to balance the tonicity of the environment. Consequently, the cell membrane shrinks, forming folds or projections.
  666. White Blood Cells
  667. FIGURE 9 White blood cells and a single squamous epithelial cell.
  668. FIGURE 10 Five white blood cells. Note that the lobed nuclei in several of these neutrophils are readily apparent, whereas in those that are degenerating, the nucleus has become mononuclear.
  669. FIGURE 11 Three white blood cells, a single red blood cell, and a squamous epithelial cell.
  670. Casts
  671. Cellular Casts
  672. FIGURE 12 A mixed cellular cast.
  673. FIGURE 13 Renal tubular epithelial cell cast with one end broken or incompletely formed.
  674. FIGURE 14 Renal tubular epithelial cell cast. Note the cuboidal shape of the entrapped cells. The nuclei were also apparent when focusing up and down during the microscopic examination.
  675. FIGURE 15 A renal tubular cell cast and several free-floating renal tubular cells in a Sternheimer-Malbin stained sediment. A highly refractile glass fragment is present in the center of this field of view.
  676. FIGURE 16 A cast with oval fat bodies (i.e., renal tubular cells that contain fat). In this Sternheimer-Malbin stained sediment, the fat globules take on a yellow or greenish appearance.
  677. FIGURE 17 A white blood cell cast. Note the spherical or round shape of entrapped cells.
  678. FIGURE 18 A mixed cell cast. This cast contains both white blood cells and red blood cells (arrow).
  679. FIGURE 19 A mixed cell cast, predominantly red blood cells.
  680. FIGURE 20 A red blood cell cast. Red blood cells are dispersed in the hyaline matrix of this cast.
  681. FIGURE 21 A red blood cell cast packed with red blood cells.
  682. FIGURE 22 A fatty cast. Note the refractility, color, and size variation of fat globules in this cast.
  683. FIGURE 23 A fatty cast loaded with fat. With the passage of time and cooling (this urine specimen was stored in a refrigerator), a cholesterol crystal (arrow) has started to form from the fat (cholesterol) in this cast.
  684. FIGURE 24 Oval fat bodies in a hyaline matrix (i.e., a fatty cast). In this sediment stained using Sudan III, the fat in the oval fat bodies has taken on the characteristic terra-cotta or red-orange color, indicating that the fat present is neutral fats (triglycerides).
  685. Granular Casts
  686. FIGURE 25 Granular cast.
  687. FIGURE 26 Granular cast.
  688. FIGURE 27 Coarsely granular cast.
  689. FIGURE 28 Cast transitioning from cellular to granular to waxy. The intense brown color suggests that pigmentation is derived from hemoglobin. This sediment also contained numerous red blood cells and red blood cell casts.
  690. FIGURE 29 Granular casts. A broad cast indicative of formation in a large collecting duct or in dilated tubules indicates significant renal pathology. The granules in these casts most likely originated from red blood cells/hemoglobin.
  691. FIGURE 30 A low-power (100×) field of view of urine sediment containing numerous casts: hyaline, granular, red blood cell, and cellular.
  692. Hyaline Casts
  693. FIGURE 31 A low-power (100×) field of view of urine sediment containing numerous hyaline casts. Because their refractive index is similar to that of urine, they can be difficult to observe on brightfield microscopy. Focusing up and down during the microscopic examination aids in the detection of hyaline casts because they are often more apparent when slightly out of focus.
  694. FIGURE 32 Hyaline cast.
  695. FIGURE 33 A U-shaped hyaline cast, two white blood cells, and several dihydrate calcium oxalate crystals.
  696. Waxy Casts
  697. FIGURE 34 A low-power (100×) field of view of a urine sediment containing numerous casts, particularly hyaline and waxy (three predominate).
  698. FIGURE 35 A long, broad waxy cast predominates in this field of view. Also present are other waxy and hyaline casts, as well as renal tubular cells and oval fat bodies.
  699. FIGURE 36 A single waxy cast and two hyaline casts. Note the difference in refractility between these two types of casts. In this image, the hyaline casts are actually out of focus, which makes them easier to see.
  700. FIGURE 37 A waxy cast (left) lying almost vertical and two red blood cell casts (right) lying horizontally.
  701. FIGURE 38 Two waxy casts. One typical in size and one broad cast that is transitioning from granular to waxy. Note ground-glass appearance and blunt end, which are characteristics of waxy casts.
  702. Crystals
  703. Ammonium Biurate Crystals
  704. FIGURE 39 Ammonium biurate crystals. Note the characteristic yellow to brown color. With the passage of time (urine storage), these crystals will grow to form spicules or thorns.
  705. Bilirubin Crystals
  706. FIGURE 40 Bilirubin crystals. Small, finely spiculated crystals with the characteristic golden yellow color indicative of bilirubin. These crystals may form when urine with large amounts of bilirubin is refrigerated and stored.
  707. Calcium Carbonate Crystals
  708. FIGURE 41 Calcium carbonate crystals (arrows) and single dihydrate calcium oxalate crystal.
  709. Calcium Oxalate Crystals
  710. FIGURE 42 A, A single dihydrate calcium oxalate crystal and numerous monohydrate calcium oxalate crystals that look similar to red blood cells. B, Same field of view using polarizing microscopy. Rule of thumb: Crystals can polarize light; red blood cells do not.
  711. FIGURE 43 Calcium oxalate crystals, atypical barrel form.
  712. FIGURE 44 Calcium oxalate crystals, atypical ovoid form.
  713. Cholesterol Crystal
  714. FIGURE 45 Cholesterol crystal (arrow).
  715. Cystine Crystal
  716. FIGURE 46 Cystine crystals. A single cystine crystal appears in the lower left corner, and several cystine crystals are layered and clustered together at the upper right corner. Several red blood cells are also present.
  717. FIGURE 47 Several cystine crystals layered and clustered together.
  718. Drug Crystals
  719. FIGURE 48 Acetylsulfadiazine crystal surrounded by numerous yeasts.
  720. FIGURE 49 Numerous sulfamethoxazole (Bactrim) crystals surrounding a single barrel-shaped uric acid crystal. Note the yellow-brown color and the similar shape of sulfamethoxazole crystals to those of ammonium biurate. Urine pH aids in differentiating these two crystals.
  721. Phosphate Crystals
  722. FIGURE 50 Triple phosphate crystals and numerous amorphous phosphates.
  723. FIGURE 51 Dissolving triple phosphate crystals and numerous amorphous phosphates.
  724. FIGURE 52 Two atypical triple phosphate crystals and a single stellate calcium phosphate crystal (upper right).
  725. FIGURE 53 Wedge-shaped calcium phosphate crystals and dihydrate calcium oxalate crystals.
  726. FIGURE 54 A calcium phosphate sheet.
  727. FIGURE 55 Calcium phosphate crystals. Unusual flat, plate-like form that layers.
  728. FIGURE 56 Calcium phosphate crystals. Uncommon slender wedges or needles.
  729. FIGURE 57 Magnesium phosphate crystals. Elongated rhomboid plates; rare.
  730. Urate Crystals
  731. FIGURE 58 Acid urate crystals. Note the yellow to brown color characteristic of thick urate crystals.
  732. FIGURE 59 Monosodium urate crystals.
  733. Uric Acid Crystals
  734. FIGURE 60 Uric acid crystals in the common diamond shape.
  735. FIGURE 61 Uric acid crystals, barrel or cube forms.
  736. FIGURE 62 A chunk of a uric acid crystal. Note the characteristic color.
  737. FIGURE 63 A single uric acid crystal in an unusual band form and numerous calcium oxalate crystals (mono- and dihydrate forms).
  738. X-Ray Contrast Media Crystals
  739. FIGURE 64 X-ray contrast media following intravenous (IV) administration (i.e., meglumine diatrizoate [Renografin]) crystals.
  740. Epithelial Cells
  741. FIGURE 65 Two squamous epithelial cells covered with bacteria, known as clue cells and a single typical or “normal” squamous epithelial cell. In urine that has been contaminated with vaginal secretions, clue cells may be observed. This is not a common occurrence.
  742. FIGURE 66 Three squamous epithelial cells and a single white blood cell. Note the similarity in size between the white blood cells and the nuclei of these epithelial cells.
  743. FIGURE 67 A squamous epithelial cell (lower left cell) and a transitional epithelial cell (upper right cell). Note the similarity in sizes of their nuclei, yet the difference in the amount of cytoplasm (i.e., different nucleus-to-cytoplasm ratios). Several large rod-shaped bacteria are also present.
  744. FIGURE 68 A typical transitional epithelial cell and a hyaline cast.
  745. FIGURE 69 A fragment of transitional epithelial cells.
  746. FIGURE 70 Transitional epithelial cell or squamous epithelial cell? Reasoning could be used to justify classification into either category. Cells lining the urinary system convert from squamous to transitional (urothelial) epithelium. This cell most likely originated from this area of transition.
  747. FIGURE 71 A transitional epithelial cell (left) and two typical cuboidal renal tubular (collecting duct) cells.
  748. FIGURE 72 Renal tubular epithelial cells. These cells came from a small collecting duct based on their cuboidal shape and their nucleus-to-cytoplasm ratio.
  749. FIGURE 73 Renal tubular epithelial cells. This fragment of columnar epithelial cells with their eccentric nuclei derived from a large collecting duct. Numerous red blood cells are also present.
  750. FIGURE 74 A single renal tubular cell (arrow) from a large collecting duct. Note the similarity in size of the nucleus of this cell to that of the red blood cells that are present.
  751. Fat GLOBULES AND OVAL FAT BODIES
  752. FIGURE 75 Several free fat globules and a fatty cast. Note refractility, variation in size, and greenish hue of the fat globules.
  753. FIGURE 76 An oval fat body in the hyaline matrix of a cast. Also present in this field of view are another free-floating oval fat body, a fat globule, and a hyaline cast. Note the similarity in size and shape of the fat globule to a red blood cell.
  754. FIGURE 77 Two oval fat bodies (arrows) loaded with fat, hence their intense refractility. Numerous red blood cells, amorphous materials, and debris are also present.
  755. FIGURE 78 Two oval fat bodies and several renal tubular cells.
  756. FIGURE 79 Three oval fat bodies. As with free-floating fat, the globules within cells often vary in size, are highly refractile, and have a greenish sheen.
  757. FIGURE 80 Several oval fat bodies enmeshed within casts and free in the urine sediment. Bacteria and spermatozoa are also present.
  758. FIGURE 81 An oval fat body engorged with fat (triglycerides or neutral fat) stained using Sudan III.
  759. Microorganisms
  760. Bacteria
  761. FIGURE 82 Numerous rod-shaped bacteria and a single dihydrate calcium oxalate crystal.
  762. FIGURE 83 Numerous bacteria, singly and in chains, with several indicated by blue arrows. Many red blood cells (RBCs) and intact and ghost cells (red arrows) are present.
  763. Trichomonads
  764. FIGURE 84 A trichomonad. Their characteristic rapid flitting motion results from their undulating membrane (blue arrow), anterior flagella (two indicated by yellow arrows), and axostyle (red arrow). Because of their size and granular appearance, nonmotile (or dead) trichomonads may be misidentified as white blood cells.
  765. FIGURE 85 Two trichomonads.
  766. FIGURE 86 A cluster of four trichomonads. It is common to observe trichomonads clustered together along with white blood cell (WBC) clumps in urine sediment.
  767. Yeast
  768. FIGURE 87 Several budding yeast (blastoconidia), bacteria, and a single ghost red blood cell. Note the refractility and sheen of the yeast, which is made most evident by focusing up and down during the microscopic examination.
  769. FIGURE 88 A branch of pseudohyphae (Candida spp.) and two red blood cells demonstrating typical pink-red coloration. Several ovoid yeasts are present in a different focal plane.
  770. FIGURE 89 Yeast cells and blastoconidia (budding yeast). These yeast cells appear more round than oval, highlighting the fact that different species of yeast will appear differently. A single dihydrate calcium oxalate crystal is also present.
  771. FIGURE 90 Early germ tube formation and several yeast cells. A single red blood cell is also present.
  772. Miscellaneous Formed Elements
  773. Hemosiderin
  774. FIGURE 91 Hemosiderin granules in urine sediment appear yellow-brown. Numerous granules as well as a clump are present in this field of view. Four granules are identified by the arrows. Two dissolving dihydrate calcium oxalate crystals are also present.
  775. FIGURE 92 Hemosiderin granules in the hyaline matrix of a cast (i.e., a hemosiderin cast).
  776. Mucus
  777. FIGURE 93 A cluster of mucous threads. Because the refractive index of muous is similar to that of urine, it can be difficult to observe using brightfield microscopy. Focusing up and down during the microscopic examination aids in the detection of mucus because it is often more apparent when slightly out of focus. A couple of squamous epithelial cells and other elements, on a different focal plane, are also present.
  778. Sperm
  779. FIGURE 94 A cluster of sperm trapped in mucus.
  780. FIGURE 95 Sperm and bacteria in urine sediment. Note that several abnormal spermatozoa forms are present.
  781. Chapter 9 Renal and Metabolic Disease
  782. Learning Objectives
  783. Key Terms
  784. Renal Diseases
  785. Glomerular Disease
  786. Box 9-1 Glomerular Diseases
  787. Primary Glomerular Diseases
  788. Secondary Glomerular Diseases
  789. Systemic Diseases
  790. Hereditary Disorders
  791. Morphologic Changes in the Glomerulus
  792. Pathogenesis of Glomerular Damage
  793. Clinical Features of Glomerular Diseases
  794. TABLE 9-1 Syndromes That Indicate Glomerular Injury
  795. TABLE 9-2 Typical Urinalysis Findings With Selected Glomerular Diseases
  796. Nephrotic Syndrome
  797. Types of Glomerulonephritis
  798. Acute Glomerulonephritis
  799. TABLE 9-3 Summary of Predominant Forms of Primary Glomerulonephritis
  800. Rapidly Progressive Glomerulonephritis
  801. Membranous Glomerulonephritis
  802. Minimal Change Disease
  803. Focal Segmental Glomerulosclerosis
  804. Membranoproliferative Glomerulonephritis
  805. IgA Nephropathy
  806. Chronic Glomerulonephritis
  807. TABLE 9-4 Percentage of Glomerular Diseases Resulting in Chronic Glomerulonephritis
  808. Systemic Diseases and Glomerular Damage
  809. FIGURE 9-1 A composite drawing showing the course of diabetic nephropathy. Exercise and other stress cause intermittent proteinuria before a sustained protein leak, which may lead to nephrotic syndrome. Initial regulation indicates initiation of insulin therapy.
  810. Tubular Disease
  811. Acute Tubular Necrosis
  812. Tubular Dysfunction
  813. Fanconi Syndrome
  814. TABLE 9-5 Proximal Tubular Dysfunctions
  815. TABLE 9-6 Distal Tubular Dysfunctions
  816. Cystinosis and Cystinuria
  817. TABLE 9-7 Typical Urinalysis Findings With Selected Tubular Diseases
  818. Renal Glucosuria
  819. Renal Phosphaturia
  820. Renal Tubular Acidosis
  821. Tubulointerstitial Disease and Urinary Tract Infections
  822. Urinary Tract Infections
  823. TABLE 9-8 Typical Urinalysis Findings in Selected Urinary Tract Infections and Tubulointerstitial Diseases
  824. Box 9-2 Causes of Tubulointerstitial Diseases
  825. Acute Pyelonephritis
  826. Chronic Pyelonephritis
  827. Acute Interstitial Nephritis
  828. Yeast Infections
  829. Vascular Disease
  830. Acute and Chronic Renal Failure
  831. Acute Renal Failure
  832. Chronic Renal Failure
  833. Calculi
  834. Pathogenesis
  835. TABLE 9-9 Renal Calculi Composition
  836. Factors Influencing Calculi Formation
  837. Prevention and Treatment
  838. Metabolic Diseases
  839. TABLE 9-10 Qualitative Tests Used to Screen for Metabolic Disorders
  840. Amino Acid Disorders
  841. Cystinosis
  842. Cystinuria
  843. Maple Syrup Urine Disease
  844. FIGURE 9-2 Major and minor pathways of phenylalanine metabolism.
  845. Phenylketonuria
  846. Alkaptonuria
  847. FIGURE 9-3 Pathways of tyrosine metabolism.
  848. Tyrosinuria
  849. Melanuria
  850. Carbohydrate Disorders
  851. Glucose and Diabetes Mellitus
  852. TABLE 9-11 Characteristics of Type 1 and Type 2 Diabetes Mellitus
  853. Galactosemia
  854. Diabetes Insipidus
  855. FIGURE 9-4 Schematic diagram of heme synthesis.
  856. Porphyrias
  857. FIGURE 9-5 The basic structure of porphyrins.
  858. TABLE 9-12 Classification of Porphyrias
  859. TABLE 9-13 Summary of Porphyria Characteristics
  860. Study Questions
  861. Case 9-1
  862. Results
  863. Case 9-2
  864. Results
  865. Case 9-3
  866. Results
  867. Case 9-4
  868. Urinalysis Results
  869. Case 9-5
  870. Urinalysis Results
  871. Case 9-6
  872. Urinalysis Results
  873. References
  874. Chapter 10 Fecal Analysis
  875. Learning Objectives
  876. Key Terms
  877. Fecal Formation
  878. Diarrhea
  879. TABLE 10-1 Classification of Diarrhea
  880. Steatorrhea
  881. TABLE 10-2 Comparison of Diarrhea and Steatorrhea
  882. Specimen Collection
  883. Patient Education
  884. TABLE 10-3 Causes of Steatorrhea
  885. Specimen Containers
  886. FIGURE 10-1 An algorithm to aid in the evaluation of diarrhea and steatorrhea. WBC, White blood cell.
  887. Type and Amount Collected
  888. Contaminants to Avoid
  889. Gas Formation
  890. Macroscopic Examination
  891. Color
  892. Consistency and Form
  893. TABLE 10-4 Fecal Macroscopic Characteristics
  894. TABLE 10-5 Fecal Reference Intervals
  895. TABLE 10-6 Disease Differentiation Based on the Presence of Fecal Leukocytes (WBCs)
  896. Mucus
  897. Odor
  898. Microscopic Examination
  899. Fecal Leukocytes
  900. Fecal Fat, Qualitative
  901. FIGURE 10-2 Numerous globules of neutral fat stained with Sudan III. The orange-red coloration is characteristic. Fat present in fecal suspension during qualitative fecal fat microscopic examination. Brightfield microscopy, 200×.
  902. FIGURE 10-3 Large globule of neutral fat stained with Sudan III. The orange-red coloration is characteristic. Brightfield microscopy, 200×.
  903. Meat Fibers
  904. FIGURE 10-4 Meat fiber (note striations on fiber) present in fecal suspension during qualitative fecal fat microscopic examination. Brightfield microscopy, 400×.
  905. Chemical Examination
  906. Fecal Blood
  907. TABLE 10-7 Fecal Occult Blood Tests
  908. TABLE 10-8 Ingested Substances Associated With Erroneous Guaiac-Based Fecal Occult Blood Tests
  909. Guaiac-Based Fecal Occult Blood Tests
  910. FIGURE 10-5 Positive guaiac-based fecal occult blood test.
  911. Immunochemical Fecal Occult Blood Tests
  912. Porphyrin-Based Fecal Occult Blood Test
  913. Fetal Hemoglobin in Feces (Apt Test)
  914. Quantitative Fecal Fat
  915. Fecal Carbohydrates
  916. Study Questions
  917. Case 10-1
  918. Urinalysis Results
  919. Microbiological Examination
  920. Blood Chemistry Results
  921. Case 10-2
  922. Microbiological Examination of Stool
  923. Case 10-3
  924. References
  925. Chapter 11 Seminal Fluid Analysis
  926. Learning Objectives
  927. Key Terms
  928. FIGURE 11-1 A schematic diagram of the male reproductive tract.
  929. Physiology
  930. FIGURE 11-2 A schematic diagram of spermatogenesis from germ cells in the seminiferous tubules.
  931. Specimen Collection
  932. TABLE 11-1 Semen Characteristics Associated With Fertility
  933. Physical Examination
  934. Appearance
  935. Volume
  936. Viscosity
  937. Microscopic Examination
  938. Motility
  939. TABLE 11-2 Sperm Motility Grading Criteria
  940. Concentration and Sperm Count
  941. FIGURE 11-3 Spermatozoon or sperm. A, A schematic of a mature sperm. B, An enlarged view of head and midpiece. C, A photomicrograph of a single sperm using phase-contrast microscopy, 400×.
  942. Postvasectomy Sperm Counts
  943. Morphology
  944. FIGURE 11-4 Sperm morphology. A, Normal spermatozoon: 1, acrosome; 2, postacrosomal cap; 3, midpiece; 4, tail. B, Large head. C, Tapered head. D, Tapered head with acrosome deficiency. E, Acrosomal deficiency. F, Head vacuole. G, Midpiece defect—cytoplasmic extrusion mass. H, Bent tail. I and J, Coiled tails. K, Double tail. L, Pairing phenomenon. M, Sperm precursors (spermatids). N, Double-headed (bicephalic) sperm.
  945. FIGURE 11-5 Sperm vitality using eosin-nigrosin (Blom’s) stain. White sperm were alive; pink-stained sperm were dead. Brightfield microscopy, 400×.
  946. Vitality
  947. Cells Other Than Spermatozoa
  948. Agglutination
  949. Chemical Examination
  950. pH
  951. Fructose
  952. Other Biochemical Markers
  953. Study Questions
  954. Case 11-1
  955. Semen Analysis
  956. Case 11-2
  957. Semen Analysis
  958. References
  959. Bibliography
  960. Chapter 12 Amniotic Fluid Analysis
  961. Learning Objectives
  962. Key Terms
  963. Physiology and Composition
  964. Function
  965. FIGURE 12-1 Schematic diagram of a fetus in utero.
  966. Formation
  967. Volume
  968. Specimen Collection
  969. Timing of and Indications for Amniocentesis
  970. TABLE 12-1 Indications for Amniocentesis
  971. Collection and Specimen Containers
  972. Specimen Transport, Storage, and Handling
  973. Differentiation From Urine
  974. Physical Examination
  975. Color
  976. Turbidity
  977. Chemical Examination
  978. Fetal Lung Maturity Tests
  979. TABLE 12-2 Fetal Lung Maturity Tests
  980. Lecithin/Sphingomyelin Ratio
  981. FIGURE 12-2 Changes in the concentrations of lecithin and sphingomyelin and changes in the lecithin/sphingomyelin ratio during normal pregnancy.
  982. Phosphatidylglycerol
  983. Foam Stability Index
  984. Fluorescence Polarization Assay
  985. Lamellar Body Counts
  986. Amniotic Fluid Bilirubin (or ΔA450 Determination)
  987. FIGURE 12-3 The determination of A450 in amniotic fluid. A, Normal amniotic fluid. B, Amniotic fluid with a bilirubin peak at 450 nm. C, Amniotic fluid with a bilirubin peak at 450 nm and contaminated with oxyhemoglobin, which peaks at 412 nm. The dashed line indicates the baseline drawn between the linear portions of the curve (i.e., between 365 and 550 nm). The red line indicates oxyhemoglobin absorbance.
  988. FIGURE 12-4 Liley’s three-zone chart (with modification) for the interpretation of amniotic fluid A450 values. The dark line extending from 22 to 38 weeks’ gestation represents the upward revision of the “danger line” by Irving Umansky.
  989. TABLE 12-3 Amniotic Fluid Reference Intervals
  990. Study Questions
  991. Case 12-1
  992. Amniotic Fluid Results
  993. References
  994. Chapter 13 Cerebrospinal Fluid Analysis
  995. Learning Objectives
  996. Key Terms
  997. Physiology and Composition
  998. FIGURE 13-1 A schematic representation of the spinal cord and the meninges that surround it.
  999. FIGURE 13-2 A schematic representation of the brain and spinal cord, including the circulation of the cerebrospinal fluid.
  1000. Specimen Collection
  1001. Box 13-1 Indications and Contraindications for Lumbar Puncture and Cerebrospinal Fluid Examination
  1002. Indications
  1003. Infections
  1004. Hemorrhage
  1005. Neurologic Disease
  1006. Malignancy
  1007. Tumor
  1008. Treatments
  1009. Contraindications
  1010. TABLE 13-1 Cerebrospinal Fluid Reference Intervals*
  1011. FIGURE 13-3 A schematic representation of a lumbar puncture procedure.
  1012. TABLE 13-2 Cerebrospinal Fluid Specimen Handling and Storage Temperature
  1013. Box 13-2 Causes of Xanthochromia in Cerebrospinal Fluid
  1014. Physical Examination
  1015. TABLE 13-3 Features That Aid in Differentiating Hemorrhage From Traumatic Tap
  1016. Microscopic Examination
  1017. Total Cell Count
  1018. Red Blood Cell (Erythrocyte) Count
  1019. White Blood Cell (Leukocyte) Count
  1020. Differential Cell Count
  1021. Techniques
  1022. Pleocytosis
  1023. Neutrophils
  1024. Lymphocytes
  1025. TABLE 13-4 Cell Types and Causes of Cerebrospinal Fluid Pleocytosis
  1026. TABLE 13-5 Normal Cerebrospinal Fluid Differential Count*
  1027. Plasma Cells
  1028. FIGURE 13-4 Low-power fields of view of cerebrospinal fluid (CSF) with tumor cell clumps. A, Rare tumor clump with numerous red blood cells (RBCs). B, Numerous cells with rare tumor clump.
  1029. FIGURE 13-5 A, Macrophage with intracellular yeast (cerebrospinal fluid [CSF], ×1000). B, Bacteria engulfed by neutrophils (CSF, ×1000).
  1030. FIGURE 13-6 Normal lymphocytes with monocyte (arrow) and red blood cell (RBC) (cerebrospinal fluid [CSF], ×1000).
  1031. FIGURE 13-7 Reactive lymphocytes (cerebrospinal fluid [CSF], ×1000).
  1032. FIGURE 13-8 Monocytes and a single neutrophil (cerebrospinal fluid [CSF], ×1000).
  1033. FIGURE 13-9 Eosinophilia in cerebrospinal fluid (CSF).
  1034. Monocytes
  1035. Eosinophils
  1036. FIGURE 13-10 Macrophage with engulfed (intracellular) red blood cells (RBCs); can also be called an erythrophage.
  1037. Macrophages
  1038. FIGURE 13-11 Hemosiderin-laden macrophage; also called a siderophage.
  1039. FIGURE 13-12 Siderophage with intracellular hematoidin crystal (cerebrospinal fluid [CSF], ×1000).
  1040. FIGURE 13-13 Clumps of ependymal or choroid plexus cells. A, Cerebrospinal fluid (CSF), ×200. B, CSF, ×500.
  1041. Other Cells
  1042. Malignant Cells
  1043. FIGURE 13-14 Lymphoblasts in cerebrospinal fluid (lymphoma).
  1044. FIGURE 13-15 Myeloblasts in cerebrospinal fluid (acute myelogenous leukemia).
  1045. Chemical Examination
  1046. Protein
  1047. Total Protein
  1048. Albumin and Immunoglobulin G
  1049. Protein Electrophoresis
  1050. FIGURE 13-16 Cerebrospinal fluid protein patterns using high-resolution electrophoresis. A, A “normal” cerebrospinal fluid protein pattern. The presence in the β2-region of τ transferrin, a protein unique to cerebrospinal fluid, is noteworthy. B, An “abnormal” cerebrospinal fluid protein pattern demonstrating the presence of oligoclonal bands in the γ region. These bands will not be present on electrophoresis of the patient’s serum. TTR, Transthyretin (previously called prealbumin).
  1051. Myelin Basic Protein
  1052. Glucose
  1053. Lactate
  1054. Microbiological Examination
  1055. Microscopic Examination of CSF Smears
  1056. Culture
  1057. Immunologic Methods
  1058. Study Questions
  1059. Case 13-1
  1060. Blood Chemistry Results
  1061. Cerebrospinal Fluid Results
  1062. Case 13-2
  1063. Blood Chemistry Results
  1064. Cerebrospinal Fluid Results
  1065. References
  1066. Chapter 14 Synovial Fluid Analysis
  1067. Learning Objectives
  1068. Key Terms
  1069. Physiology and Composition
  1070. FIGURE 14-1 A schematic representation of the knee: a diarthrodial joint.
  1071. FIGURE 14-2 Synoviocytes in synovial fluid, ×400. Note similarity to mesothelial cells.
  1072. TABLE 14-1 Synovial Fluid Reference Intervals*
  1073. Classification of Joint Disorders
  1074. TABLE 14-2 Classification of Synovial Fluid Based on Laboratory Examination
  1075. Specimen Collection
  1076. TABLE 14-3 Synovial Fluid Analysis and Specimen Requirements
  1077. Physical Examination
  1078. Color
  1079. Clarity
  1080. Viscosity
  1081. Clot Formation
  1082. Microscopic Examination
  1083. Total Cell Count
  1084. Differential Cell Count
  1085. TABLE 14-4 Synovial Fluid Crystal Identification, Microscopic Characteristics, and Associated Clinical Conditions
  1086. Crystal Identification
  1087. Microscope Slide Preparations
  1088. Monosodium Urate Crystals
  1089. FIGURE 14-3 A, A diagrammatic representation of monosodium urate and calcium pyrophosphate crystals when viewed using polarizing microscopy with a red compensator. The axis indicated is that of the compensator. B, Monosodium urate crystals in joint fluid. The crystals with their longitudinal axis parallel to the red compensator plate axis as indicated in the lower left corner are yellow. C, With the axis of the red compensator plate perpendicular to the longitudinal axis, the same monosodium urate crystals are blue (polarizing microscopy).
  1090. Calcium Pyrophosphate Dihydrate Crystals
  1091. FIGURE 14-4 A, Calcium pyrophosphate dihydrate crystal in joint fluid; brightfield microscopy. B, Calcium pyrophosphate dihydrate crystal appears yellow; its axis is perpendicular to the axis of the red compensator plate (polarizing microscopy). C, Calcium pyrophosphate dihydrate crystal appears blue; its axis is parallel to that of the red compensator plate (polarizing microscopy).
  1092. Cholesterol Crystals
  1093. Hydroxyapatite Crystals
  1094. FIGURE 14-5 Cholesterol crystals in joint fluid; brightfield microscopy.
  1095. FIGURE 14-6 Synovial fluid with corticosteroid drug (triamcinolone diacetate [Aristocort]) crystals present. Note their conflicting morphology (suggests calcium pyrophosphate dihydrate [CPPD]) and strong negative birefringence (suggests monosodium urate [MSU]). Wet preparation, unstained; polarizing microscopy, 400×. A, Many strongly birefringent drug crystals that morphologically resemble CPPD using polarizing microscopy. B, Drug crystals with their long axes parallel to that of the red compensator plate are yellow—suggesting MSU crystals.
  1096. Corticosteroid Crystals
  1097. Artifacts
  1098. FIGURE 14-7 Synovial fluid with mass of hyaluronate, small monosodium urate (MSU) crystals, starch granule, and fibers. Cytocentrifuged preparation, Wright’s stain, 400×. A, Brightfield microscopy; starch granule and fiber. Note that no crystals are evident in the pink mass. B, Polarizing microscopy; presence of MSU crystals is evident, fibers have strong birefringence, and the starch granule shows a typical Maltese cross-pattern. C, Compensated polarizing microscopy; crystals with their long axis perpendicular to the red compensator plate are blue, which indicates that the crystals are MSU.
  1099. Chemical Examination
  1100. Glucose
  1101. Total Protein
  1102. Uric Acid
  1103. Lactate
  1104. Microbiological Examination
  1105. Gram Stain
  1106. Culture and Molecular Methods
  1107. Study Questions
  1108. Case 14-1
  1109. Blood Chemistry Results
  1110. Synovial Fluid Results
  1111. Case 14-2
  1112. Blood Chemistry Results
  1113. Synovial Fluid Results
  1114. Case 14-3
  1115. Blood Chemistry Results
  1116. Synovial Fluid Results
  1117. References
  1118. Bibliography
  1119. Chapter 15 Pleural, Pericardial, and Peritoneal Fluid Analysis
  1120. Learning Objectives
  1121. Key Terms
  1122. Physiology and Composition
  1123. FIGURE 15-1 Parietal and visceral membranes of the pleural, pericardial, and peritoneal cavities. Parietal membranes line the body wall, whereas visceral membranes enclose organs. The two membranes are actually one continuous membrane. The space between opposing surfaces is identified as the body cavity (i.e., pleural cavity, pericardial cavity, peritoneal cavity).
  1124. Box 15-1 Forces Involved in Normal Pleural Fluid Formation and Absorption
  1125. TABLE 15-1 Suggested Serous Fluid Specimen Requirements
  1126. Specimen Collection
  1127. Transudates and Exudates
  1128. TABLE 15-2 Differentiation of Transudates and Exudates
  1129. Physical Examination
  1130. TABLE 15-3 Serous Effusions: Types, Mechanism of Formation, and Associated Conditions
  1131. TABLE 15-4 Differentiation of Chylous and Pseudochylous Effusions
  1132. Microscopic Examination
  1133. Total Cell Counts
  1134. Differential Cell Count
  1135. Microscope Slide Preparation
  1136. Cell Differential
  1137. FIGURE 15-2 Mesothelial cells, macrophages, neutrophils, and lymphocytes in peritoneal fluid, Wright’s stain, 200×.
  1138. FIGURE 15-3 Macrophages in peritoneal (ascites) fluid. Cytocentrifuged smear, Wright’s stain, 500×.
  1139. FIGURE 15-4 A signet ring macrophage and some red blood cells (RBCs) in pleural fluid. Cytocentrifuged smear, Wright’s stain, 400×.
  1140. FIGURE 15-5 Plasma cells in pleural fluid (1000×).
  1141. FIGURE 15-6 Lupus erythematosus (LE) cell in pleural fluid, 1000× (Wright’s stain). The engulfed homogeneous mass pushes the nucleus of the neutrophil to the periphery of the cell.
  1142. FIGURE 15-7 A, Mesothelial cell in pleural fluid, 1000× (Wright’s stain). B, Binucleated mesothelial cell with basophilic cytoplasm, pleural fluid, 1000× (Wright’s stain). C, Clump of mesothelial cells in pleural fluid, 500× (Wright’s stain).
  1143. Cytologic Examination
  1144. Chemical Examination
  1145. FIGURE 15-8 Adenocarcinoma in peritoneal fluid. Cytocentrifuged smear, Wright’s stain, 400×.
  1146. Total Protein and Lactate Dehydrogenase Ratios
  1147. Glucose
  1148. Amylase
  1149. Lipids (Triglyceride and Cholesterol)
  1150. pH
  1151. Carcinoembryonic Antigen
  1152. Microbiological Examination
  1153. Staining Techniques
  1154. Culture
  1155. Study Questions
  1156. Case 15-1
  1157. Blood Chemistry Results
  1158. Pleural Fluid Results
  1159. Case 15-2
  1160. Blood Chemistry Results
  1161. Peritoneal Fluid Results
  1162. References
  1163. Bibliography
  1164. Chapter 16 Analysis of Vaginal Secretions
  1165. Learning Objectives
  1166. Key Terms
  1167. TABLE 16-1 Vaginal Secretion Findings and Associated Conditions
  1168. Specimen Collection and Handling
  1169. pH
  1170. Microscopic Examinations
  1171. Wet Mount Examination
  1172. TABLE 16-2 Quantification Criteria for Microscopic Examinations
  1173. Blood Cells
  1174. Bacterial Flora
  1175. FIGURE 16-1 Large rods characteristic of Lactobacillus spp. surrounding a typical squamous epithelial cell from a healthy vagina.
  1176. Yeast
  1177. Epithelial Cells
  1178. FIGURE 16-2 Yeast and pseudohyphae in the wet mount of a vaginal secretions specimen. A, Budding yeast (blastoconidia) and two squamous epithelial cells. B, Pseudohyphae.
  1179. FIGURE 16-3 Several squamous epithelial cells from a healthy vagina. Keratohyalin granulation is most pronounced in the centrally located cell. Numerous large rods characteristic of Lactobacillus spp. are also present.
  1180. FIGURE 16-4 Two clue cells (arrows) and several normal squamous epithelial cells in the wet mount of a vaginal secretions specimen.
  1181. FIGURE 16-5 A single parabasal cell surrounded by numerous squamous epithelial cells.
  1182. Trichomonads
  1183. FIGURE 16-6 Schematic diagram of Trichomonas vaginalis.
  1184. FIGURE 16-7 Two trichomonads. Visible on the upper organism are three of the four anterior flagella (upper arrow), a portion of the undulating membrane (lower arrow), and the posterior axostyle.
  1185. KOH Preparation and Amine Test
  1186. Clinical Correlations
  1187. Bacterial Vaginosis
  1188. Candidiasis
  1189. Trichomoniasis
  1190. Atrophic Vaginitis
  1191. Study Questions
  1192. Case 16-1
  1193. Vaginal Secretion Results
  1194. References
  1195. Bibliography
  1196. Chapter 17 Automation of Urine and Body Fluid Analysis
  1197. Learning Objectives
  1198. Key Terms
  1199. Automation of Urinalysis
  1200. Urine Chemistry Analyzers
  1201. Principle of Reflectance Photometry
  1202. Semi-Automated Chemistry Analyzers
  1203. TABLE 17-1 Selected Urine Chemistry Analyzers
  1204. FIGURE 17-1 Diascreen 50 semi-automated urine chemistry analyzer.
  1205. FIGURE 17-2 iChem 100 semi-automated urine chemistry analyzer.
  1206. FIGURE 17-3 CLINITEK Advantus semi-automated urine chemistry analyzer.
  1207. Fully Automated Chemistry Analyzers
  1208. FIGURE 17-4 Rack of specimen tubes at the barcode reading and sampling station on the iChem Velocity.
  1209. TABLE 17-2 Typical Features of Semi-automated Urine Chemistry Analyzers
  1210. Automated Microscopy Analyzers
  1211. FIGURE 17-5 CLINITEK Atlas, an automated urine chemistry analyzer.
  1212. FIGURE 17-6 AUTION Max AX-4030, an automated urine chemistry analyzer.
  1213. FIGURE 17-7 iChem Velocity fully automated urine chemistry analyzer.
  1214. FIGURE 17-8 iQ200 microscopy analyzer.
  1215. FIGURE 17-9 Sysmex UF1000i analyzer.
  1216. FIGURE 17-10 Diagram of the iQ200 digital flow capture process.
  1217. iQ200 Urine Microscopy Analyzer
  1218. FIGURE 17-11 Auto-Particle Recognition (APR) process.
  1219. FIGURE 17-12 Displays of iQ200 urinalysis results. A, On-screen review of iQ200 results. The results for this sample did not auto-release because the amount of some microscopic elements resided in the “Particle Verification Range” set by the user. These results appear “yellow” and require review as established by this laboratory. Results that appear “green” are in the normal range and those that appear “red” are considered abnormal but do not need verification (as established by the user-defined criteria). When no yellow results are present, results can be automatically released without review or verification. B, On-screen display of automatically classified images of budding yeast (BYST).
  1220. TABLE 17-3 iQ200 Autoclassification and Subclassification Categories for Urine Sediment Particles
  1221. Sysmex UF-1000I and UF-100 Flow Cytometers
  1222. FIGURE 17-13 Diagram of urine particle analysis in the Sysmex UF-1000i.
  1223. FIGURE 17-14 Sysmex UF-1000i urine particle results. A, Scattergram of forward scatter (S_FSC) versus fluorescent light intensity-high sensitivity (S_FLH). B, Scattergram of forward scatter (S_FSC) versus fluorescent light intensity–low sensitivity (S_FLL). EC, Epithelial cells; RBC, red blood cells; WBC, white blood cells; YLC, yeastlike cells.
  1224. TABLE 17-4 UF-1000i Particle Detection Categories
  1225. Fully Automated Urinalysis Systems
  1226. TABLE 17-5 Fully Automated Urinalysis (UA) Systems
  1227. iRICELL Urinalysis Systems
  1228. CLINITEK AUWi System
  1229. FIGURE 17-15 iRICELL3000, a Fully Automated Urinalysis System that combines the iChem Velocity urine chemistry analyzer and the iQ200 microscopy analyzer.
  1230. FIGURE 17-16 AUWi, a Fully Automated Urinalysis System that combines the Siemens CLINITEK Atlas chemistry analyzer and the Sysmex UF-1000i particle analyzer.
  1231. Automation of Body Fluid Analysis
  1232. Body Fluid Cell Counts Using Hematology Analyzers
  1233. TABLE 17-6 Selected Automated Body Fluid Analyzers
  1234. Body Fluid Cell Counts Using iQ200
  1235. Study Questions
  1236. References
  1237. Chapter 18 Body Fluid Analysis: Manual Hemacytometer Counts and Differential Slide Preparation
  1238. Learning Objectives
  1239. Using A Hemacytometer
  1240. Diluents and Dilutions
  1241. TABLE 18-1 Body Fluid Dilution Guideline for Cell Counts Based on Visual Appearance
  1242. Box 18-1 Enhancing Visualization of WBCs When Analyzing Clear Fluids
  1243. TABLE 18-2 Diluents for Body Fluid Blood Cell Counts*
  1244. Pretreatment and Dilution of Synovial Fluid Specimens
  1245. Semen Dilution and Pretreatment of Viscous Specimens
  1246. Hemacytometer Cell Counts
  1247. Box 18-2 Manual Cell Count Using a Hemacytometer
  1248. FIGURE 18-1 Top, View of a hemacytometer chamber with an “improved” Neubauer etched grid or rulings. Middle, A single “W” square that is 1 mm2; notation derived from the use of 5 “W-sized” squares to enumerate white blood cells. A single “R” square that is 0.04 mm2; notation derived from the used of 5 “R-sized” squares to enumerate red blood cells. Bottom, Side view of hemacytometer chamber demonstrating how glass coverslip rests on ridges of hemacytometer and that when properly filled, the volume of liquid in the chamber has a fixed depth of 0.1 mm.
  1249. Calculations
  1250. Hemacytometer Calculation Examples
  1251. Example A: Using Undiluted Body Fluid
  1252. Example B: Using Diluted Body Fluid
  1253. Example C: Sperm Count Using Diluted Semen
  1254. Preparation of Slides for Differential
  1255. FIGURE 18-2 Thermo-Scientific Cytospin 4 cytocentrifuge
  1256. Cytocentrifugation
  1257. FIGURE 18-3 A, The components of an assembly for the Cytospin 4 cytocentrifuge consist of a stainless steel holder (Cytoclip), a chamber with attached filter card (Cytofunnel), and a microscope slide. Note that the opening in the filter paper is the site where sample flows from the chamber to the glass slide. B, Assembly ready for addition of body fluid and then placement onto the rotor of the cytocentrifuge.
  1258. FIGURE 18-4 Cytocentrifuge prepared slides of two body fluids stained using Wright stain. The upper slide shows a visually evident cell button in the area circled by a wax pencil. In contrast, the cell button is not macroscopically evident on the lower slide. On this slide, the wax pencil circle greatly aids the microscopist in locating the proper area of the slide for viewing.
  1259. TABLE 18-3 Guideline for Body Fluid Volume When Preparing Slide by Cytocentrifugation
  1260. TABLE 18-4 Distortions Associated With Cytocentrifugation
  1261. Slide Preparations
  1262. Study questions
  1263. References
  1264. Glossary
  1265. A
  1266. B
  1267. C
  1268. D
  1269. E
  1270. F
  1271. G
  1272. H
  1273. I
  1274. J
  1275. K
  1276. L
  1277. M
  1278. N
  1279. O
  1280. P
  1281. Q
  1282. R
  1283. S
  1284. T
  1285. U
  1286. V
  1287. X
  1288. Y
  1289. Answer Key
  1290. Chapter 1
  1291. Chapter 2
  1292. Case 2-1
  1293. Chapter 3
  1294. Chapter 4
  1295. Chapter 5
  1296. Case 5-1
  1297. Case 5-2
  1298. Chapter 6
  1299. Case 6-1
  1300. Case 6-2
  1301. Chapter 7
  1302. Case 7-1
  1303. Case 7-2
  1304. Case 7-3
  1305. Case 7-4
  1306. Case 7-5
  1307. Case 7-6
  1308. Chapter 8
  1309. Case 8-1
  1310. Case 8-2
  1311. Case 8-3
  1312. Case 8-4
  1313. Case 8-5
  1314. Case 8-6
  1315. Case 8-7
  1316. Chapter 9
  1317. Case 9-1
  1318. Case 9-2
  1319. Case 9-3
  1320. Case 9-4
  1321. Case 9-5
  1322. Case 9-6
  1323. Chapter 10
  1324. Case 10-1
  1325. Case 10-2
  1326. Case 10-3
  1327. Chapter 11
  1328. Case 11-1
  1329. Case 11-2
  1330. Chapter 12
  1331. Case 12-1
  1332. Chapter 13
  1333. Case 13-1
  1334. Case 13-2
  1335. Chapter 14
  1336. Case 14-1
  1337. Case 14-2
  1338. Case 14-3
  1339. Chapter 15
  1340. Case 15-1
  1341. Case 15-2
  1342. Chapter 16
  1343. Case 16-1
  1344. Chapter 17
  1345. Chapter 18
  1346. Appendix A Reagent Strip Color Charts
  1347. FIGURE A-1 A, vChem strip. B, vChem 10SG color chart. Do not use this color chart for diagnostic testing; use chart provided with product.
  1348. FIGURE A-2 A, Multistix strip. B, Multistix 10SG color chart. Do not use this color chart for diagnostic testing; use chart provided with product.
  1349. FIGURE A-3 Manufacturers vary in the proper orientation of the reagent strip to the color chart on the container when reading results. A, vChem 10SG Reagent Strips. B, Multistix 10SG Reagent Strips.
  1350. Appendix B Reference Intervals
  1351. Urine (Random Specimen) Reference Intervals
  1352. Fecal Reference Intervals
  1353. Semen Characteristics Associated With Fertility
  1354. Amniotic Fluid Reference Intervals
  1355. Synovial Fluid Reference Intervals*
  1356. Cerebrospinal Fluid Reference Intervals*
  1357. Appendix C Body Fluid Diluent and Pretreatment Solutions
  1358. Outline
  1359. Saline, Isotonic (0.85%) or “Normal Saline”
  1360. Saline, Hypotonic (0.30%)
  1361. Dilute Acetic Acid (3.0%)
  1362. Turk’s Solution2
  1363. 0.5% Methylene Blue Solution (Used to Prepare Turk’s Solution)
  1364. TABLE C-1 Common Uses and Limitations of Diluents
  1365. Synovial Fluid Solutions
  1366. Hyaluronidase Pretreatment for Synovial Fluid3
  1367. 0.05% Buffered Hyaluronidase
  1368. Hyaluronidase (0.1 g/L) Diluent for Cell Counts in Synovial Fluid2
  1369. Semen Solutions
  1370. Semen Pretreatment Solutions
  1371. A Dilution With Physiologic Solution
  1372. Dulbecco’s Phosphate-Buffered Saline (pH 7.4)4
  1373. B Digestion With Bromelain
  1374. Bromelain Solution (10 IU/mL)4
  1375. Semen Diluent for Sperm Counts
  1376. References
  1377. Index
  1378. A
  1379. B
  1380. C
  1381. D
  1382. E
  1383. F
  1384. G
  1385. H
  1386. I
  1387. J
  1388. K
  1389. L
  1390. M
  1391. N
  1392. O
  1393. P
  1394. Q
  1395. R
  1396. S
  1397. T
  1398. U
  1399. V
  1400. W
  1401. X
  1402. IFC
  1403. Quick Guide to Figures
  1404. Blood Cells
  1405. Casts
  1406. Crystals (according to pH)
  1407. Epithelial Cells
  1408. Fat
  1409. Microorganisms (alphabetical order)
  1410. Miscellaneous Elements